Global Clinical Strategy Director - VP

Shape Global Clinical Development Strategies

Are you ready to lead late-stage oncology programmes and bring life-changing therapies closer to patients worldwide? Join a dynamic and innovative team in the biotechnology sector to advance clinical strategies for oncology, immuno-oncology, and other severe conditions with unmet medical needs.

Primary Responsibilities

• Lead late-stage clinical development programs, including Phase III trials through BLA/NDA submissions.
• Oversee and participate in Multi-Regional Clinical Trials (MRCTs), particularly in the US and EU.
• Drive global clinical strategy decision-making to support product registration.
• Collaborate closely with cross-functional teams to ensure alignment with regulatory and clinical development pathways.
• Provide strategic input into the development of therapies in oncology, immuno-oncology, autoimmune diseases, and other serious conditions.
• Report directly to the Chief Medical Officer, contributing to high-level organizational goals.

Skills & Requirements

• MD degree or equivalent qualification.
• Strong expertise in late-stage clinical development, including hands-on experience with Phase III trials and regulatory submissions.
• Proven track record in leading or participating in MRCTs.
• In-depth knowledge of global regulatory and clinical development pathways.
• Therapeutic focus on oncology and immuno-oncology, with broader interests in autoimmune and severe diseases.
• Demonstrated ability to make impactful decisions in global clinical strategy.

Compensation

$250,000.00 - $350,000.00/Annum